# Safety and Efficacy Study of Omalizumab Given Prior to Immunotherapy

> **NCT00329381** · PHASE4 · COMPLETED · sponsor: **University of Mississippi Medical Center** · enrollment: 14 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Xolair
- **DRUG:** Xolair

## Key facts

- **NCT ID:** NCT00329381
- **Lead sponsor:** University of Mississippi Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** 2007-05
- **Final completion:** 2007-10
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2008-06-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00329381

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00329381, "Safety and Efficacy Study of Omalizumab Given Prior to Immunotherapy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00329381. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*